Q3 2025 Earnings Call Transcript October 29, 2025 AxoGen, Inc. beats earnings expectations. Reported EPS is $0.12, ...
“The latest results show that PSA screening in this trial prevented 22 prostate cancer deaths per 10,000 men screened, compared to 14 deaths in the previous analysis. It also shows that the harms of ...
Axogen, Inc. ( AXGN) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT ...
Detailed price information for Procept Biorobotics Corp (PRCT-Q) from The Globe and Mail including charting and trades.
Understand the impact of robotic-assisted prostate cancer surgery and real-time analysis on surgical precision and patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback